The role of Epstein-Barr virus in multiple sclerosis: From pathogenesis to therapeutic potential

G Bellucci1, R Mechelli2, R Bigi3

  • 1Department of Neurosciences, Mental Health and Sensory Organs, Sapienza University of Rome, 00189 Rome, Italy; Department of Neurology, University of California, San Francisco, CA, United States.

Revue Neurologique
|April 23, 2026
PubMed

Insights

Epstein-Barr virus (EBV) infection is a necessary precursor to multiple sclerosis (MS) development. This review synthesizes evidence to model EBV

Area of Science:

  • Neuroimmunology
  • Virology
  • Epidemiology

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with complex etiology.
  • Epstein-Barr virus (EBV) infection is increasingly implicated in MS pathogenesis.
  • The link between EBV and MS requires further elucidation.

Purpose of the Study:

  • To synthesize current evidence on the role of EBV in multiple sclerosis.
  • To construct a model of EBV-driven MS pathogenesis.
  • To explore therapeutic strategies targeting EBV for MS prevention and treatment.

Main Methods:

  • Review of epidemiological, pathological, and immunogenetic studies.
  • Analysis of clinical-therapeutic data.
  • Synthesis of evidence to propose a pathogenetic model.

Main Results:

  • EBV infection precedes MS onset and is a necessary precondition.
  • EBV-infected B cells are found in CNS lesions.
  • EBV reshapes B cell function, promotes molecular mimicry, and drives neuroinflammation.

Conclusions:

  • EBV is a central factor in MS pathogenesis.
  • Current MS therapies have varying interactions with EBV biology.
  • EBV-targeted strategies, including vaccines and antivirals, offer potential for MS prevention and early intervention.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
14
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
55
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
13